The Immune System
Under Control
Our Company
AbolerIS Pharma is a Belgian biopharmaceutical company developing a novel approach to the treatment of chronic autoimmune and inflammatory diseases.
Lead Program
AbolerIS Pharma is developing a first-in-class monoclonal antibody based on a novel scientific approach to restore the balance in the immune system.
Our novel and unique therapeutic approaches induce immune tolerance and preserve useful immune responses in inflammatory, autoimmune, and degenerative diseases.
Latest updates

11 - 14 June 2025Barcelona,SpainThe EULAR European Congress of Rheumatology is an esteemed flagship event, consistently delivering an unparalleled experience year after year. The Congress serves as a unifying platform…